Active	Status	Sponsor type	Region	Phase	Filter
11 Active 0 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ta, Janice
NCT04450693: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)	Recruiting	3	220	US	TTAX01, Standard care	Tissue Tech Inc.	Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer	09/24	09/24
NCT04015128: A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT	Recruiting	N/A	60	US	Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System	Stryker Trauma and Extremities	Femoral Fracture	12/24	12/24
NCT04317586: Trident II Revision Outcomes Study	Terminated	N/A	17	US	Trident II Tritanium Acetabular Shell for Revision	Stryker Orthopaedics	Arthroplasty, Hip Revision	01/23	01/23
OR3O, NCT04325022: Safety and Effectiveness Study of ™ Dual Mobility System in THA	Recruiting	N/A	400	Canada, US, RoW	Primary Total Hip Arthroplasty, Revision Total Hip Arthroplasty	Smith & Nephew, Inc.	Advanced Degeneration of the Hip Joint, Revision of the Hip Joint	10/36	01/37
Oguchi, Godson
VIVID-2, NCT04232553 / 2019-002687-27: A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	Recruiting	3	778	Europe, Canada, Japan, US, RoW	Mirikizumab, LY3074828	Eli Lilly and Company	Crohn's Disease	01/25	12/26
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis	Recruiting	2b	126	US	Phage Therapy, Placebo	Adaptive Phage Therapeutics, Inc., United States Department of Defense	Osteomyelitis, Diabetic Foot Osteomyelitis	04/24	12/24
COMET-PACE, NCT05124210 / 2021-003717-18: Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19	Terminated	2	8	US	Sotrovimab	GlaxoSmithKline, Vir Biotechnology, Inc.	COVID-19	06/23	06/23
NCT06214052: VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1	Recruiting	2	28	Europe, Canada, US, RoW	VH4524184, Placebo	ViiV Healthcare, GlaxoSmithKline	HIV Infections	09/24	09/24
CINNAMON, NCT06039579: Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults	Active, not recruiting	2	43	Europe, Canada, US, RoW	VH4004280, VH4011499, VH4004280 Matching Placebo, VH4011499 Matching Placebo	ViiV Healthcare	HIV Infections	06/24	06/24
Villaruel, Stacey-Ann
NCT04450693: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)	Recruiting	3	220	US	TTAX01, Standard care	Tissue Tech Inc.	Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer	09/24	09/24
Chokr, Numaliz
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis	Recruiting	2b	126	US	Phage Therapy, Placebo	Adaptive Phage Therapeutics, Inc., United States Department of Defense	Osteomyelitis, Diabetic Foot Osteomyelitis	04/24	12/24